Proton Therapy Industry 2017 Market Size, Share and Growth 2021 Proton Therapy Market United States Analysis 2017 | Page 2

Proton Therapy Market - United States Industry Analysis, Size, Share,
Growth, Trends and Forecasts 2017 – 2022
“United States Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy
Centers and Forecast to 2022” provides a comprehensive assessment of the fast-evolving, high-growth
Proton Therapy Market.
The unprecedented demand of proton therapy for the treatment of cancer has set the stage for the market
to move ahead at a rapid pace. Proton therapy is an advanced form of radiation therapy that uses high-
energy proton beam rather than conventional radiotherapy to irradiate a tumor. The main advantage of
proton therapy is that while destroying the target malignant cells, it causes minimal damage to the
surrounding cells.
Company Coverage of United States Proton Therapy Market: IBA, Optivus, Hitachi, Mevion, Varian.
The number of proton therapy centers is increasing in United States. Still, industry experts believe that
players will miss out on a majority of cancer patients who can benefit with proton therapy, overlooking a
huge multi-Billion-dollar potential market. The numbers of patients treated with Proton Therapy is very low
whereas; the potential candidates for proton therapy are huge. IBA dominates the proton therapy market.
However, other players like Varian, Mevion, Hitachi etc. have also started to make their presence felt in the
market.
The number of proton therapy centers in United States is anticipated to increase year on year, which in
turn, will result in more clinical research, better clinician understanding and greater patient awareness of its
benefits-which will help drive the further growth.
Complete report available at http://www.marketreportsonline.com/584685.html